Covered recipient · General Payments record
MICHAEL C VERONESI
Allopathic & Osteopathic Physicians Radiology Neuroradiology
General Payments · PY2023–2024
$20,476.60
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,500.00 | 2 |
| Travel and Lodging | $3,911.19 | 2 |
| Food and Beverage | $594.74 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Telix Pharmaceuticals | $10,005.93 | 12 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Telix Pharmaceuticals | $1,936.67 | 02/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1081986054 | CMS |
| Telix Pharmaceuticals | $4,000.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1081986056 | CMS |
| Telix Pharmaceuticals | $59.50 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986058 | CMS |
| Telix Pharmaceuticals | $104.64 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986060 | CMS |
| Telix Pharmaceuticals | $132.26 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986062 | CMS |
| Telix Pharmaceuticals | $24.09 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986064 | CMS |
| Telix Pharmaceuticals | $116.55 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986066 | CMS |
| Telix Pharmaceuticals | $27.29 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986068 | CMS |
| Telix Pharmaceuticals | $47.51 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986070 | CMS |
| Telix Pharmaceuticals | $1,974.52 | 06/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1081986072 | CMS |
| Telix Pharmaceuticals | $1,500.00 | 08/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1081986074 | CMS |
| Telix Pharmaceuticals | $82.90 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081986076 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.